Literature DB >> 10729688

Incorporating patient preferences into randomized trials.

M F Lambert1, J Wood.   

Abstract

When designing trials, an important ethical and practical concern is ensuring that proper consideration is given to patient preferences. A number of design variants on the traditional randomized trial can take account of such preferences in different ways. The partially randomized patient preference (PRPP) design is often advocated for taking these preferences into account. In studies of this type, all eligible patients are followed up, but the primary comparison is still between effects observed in patients randomly allocated to treatment arms. This design and other variants on conventional trials each have different scientific, ethical, and practical implications. We consider these diverse aspects of several modifications to the conventional method for obtaining consent and then, in more detail, the relative merits of the PRPP design. We conclude that none of these adjustments is ideal. Those designing trials should therefore always think carefully about the consent process, for its implications on participation and on how the results will be interpreted.

Entities:  

Mesh:

Year:  2000        PMID: 10729688     DOI: 10.1016/s0895-4356(99)00146-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

1.  Modified informed consent procedure: consent to postponed information.

Authors:  Han Boter; Johannes J M van Delden; Rob J de Haan; Gabriël J E Rinkel
Journal:  BMJ       Date:  2003-08-02

2.  Physiotherapy or corticosteroid injection for shoulder pain?

Authors:  D A W M van der Windt; L M Bouter
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

3.  Patients' evaluation of informed consent to postponed information: cohort study.

Authors:  Han Boter; Johannes J M van Delden; Rob J de Haan; Gabriël J E Rinkel
Journal:  BMJ       Date:  2004-06-21

4.  Noncompliance in randomized controlled trials.

Authors:  Jeevan P Marasinghe; A A W Amarasinghe
Journal:  CMAJ       Date:  2007-06-05       Impact factor: 8.262

5.  Impact of referral source and study applicants' preference for randomly assigned service on research enrollment, service engagement, and evaluative outcomes.

Authors:  Cathaleene Macias; Paul Barreira; William Hargreaves; Leonard Bickman; William Fisher; Elliot Aronson
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

6.  Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine: executive summary.

Authors:  Jian-Ping Liu; Ke-Ji Chen
Journal:  Complement Ther Med       Date:  2015-10       Impact factor: 2.446

7.  Preference in random assignment: implications for the interpretation of randomized trials.

Authors:  Cathaleene Macias; Paul B Gold; William A Hargreaves; Elliot Aronson; Leonard Bickman; Paul J Barreira; Danson R Jones; Charles F Rodican; William H Fisher
Journal:  Adm Policy Ment Health       Date:  2009-05-12

8.  A new complementary approach for oral health and diabetes management: health coaching.

Authors:  Ayse Basak Cinar; Ruth Freeman; Lone Schou
Journal:  Int Dent J       Date:  2017-09-14       Impact factor: 2.607

9.  Feasibility of Conducting a Trial Assessing Benefits and Risks of Planned Caesarean Section Versus Planned Vaginal Birth: A Cross-Sectional Study.

Authors:  Melissa M Amyx; Fernando Althabe; Julie Rivo; Verónica Pingray; Nicole Minckas; María Belizán; Luz Gibbons; Gerardo T Murga; Ángel E Fiorillo; Julio D Malamud; Roberto A Casale; Gabriela Cormick; José M Belizán
Journal:  Matern Child Health J       Date:  2021-01-03

10.  Using a partially randomized patient preference study design to evaluate the therapeutic effect of acupuncture and cupping therapy for fibromyalgia: study protocol for a partially randomized controlled trial.

Authors:  Hui-Juan Cao; Jian-Ping Liu; Hui Hu; Nissi S Wang
Journal:  Trials       Date:  2014-07-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.